small molecule bet inhibitor (Boehringer Ingelheim)
86
Structured Review
Boehringer Ingelheim
small molecule bet inhibitor
Small Molecule Bet Inhibitor, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/small+molecule+bet+inhibitor/bet+inhibitor+molecule+small/pm41056820-154-5-10
Average 86 stars, based on 1 article reviews
Small Molecule Bet Inhibitor, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/small+molecule+bet+inhibitor/bet+inhibitor+molecule+small/pm41056820-154-5-10
Average 86 stars, based on 1 article reviews
small molecule bet inhibitor - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
other:Article Title: Recent advances and strategies in BET bromodomain inhibition for drug discovery. Article Snippet: BET proteins, which function as epigenetic readers to modulate gene expression and drive cancer progression, have emerged as promising targets for novel epigenetic anticancer therapies.. Although preclinical models and initial clinical trials have demonstrated the anticancer potential of BET inhibitors, Pan-BET inhibitors often exhibit unsatisfied tolerability, dose-limiting toxicities, and limited efficacy as monotherapies.. Recent studies highlight that selective BET inhibitors targeting individual bromodomains (BET-BD1 or BET-BD2) offer distinct advantages over pan-inhibitors, including reduced toxicity profiles. |